Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
Clinical trial NCT03400943 · TERMINATED
Trial details
- NCT number
- NCT03400943
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2019-06-09
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.